Literature DB >> 33340599

Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.

Shanshan Wang1, Yun Li2, Wenzhi Li2, Kun Zhang1, Zhengqiang Yuan1, Yina Cai1, Kuncheng Xu1, Jinrong Zhou3, Zhiyun Du4.   

Abstract

ETHNO PHARMACOLOGICAL RELEVANCE: Curcuma longa L is traditionally used as an anti-inflammatory remedy in Chinese traditional medicine. Curcuma oil (CO), a lipophilic fraction from Curcuma longa L. has been reported to have anti-proliferative, anti-inflammatory and anti-oxidant activities. However, CO has never been investigated for its possible therapeutic effects on benign prostatic hyperplasia (BPH). AIMS OF THE STUDY: The study is thus to determine the therapeutic effects of curcuma oil on BPH and also the possible mechanism (s) of action. MATERIALS &
METHODS: A BPH-1 cell line and Sprague Dawley (SD) rats were used to establish BPH models in vitro and in vivo, respectively. Rats were treated by CO (2.4, 7.2 mg/kg/i.g.) and finasteride (5 mg/kg/i.g.), respectively. Histological changes were examined by hematoxylin and eosin (H&E) staining. Protein expression was analyzed for 5α-reductase (5AR), dihydrotestosterone (DHT), interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α by ELISA. Ki-67, Caspase-8,-9 and -3 expressions were evaluated via immunohistochemistry (IHC).
RESULTS: CO effectively induced apoptosis in BPH-1 cells. BPH was successfully established by administration of testosterone propionate (TP) in rats, which upregulated both 5α-reductase expression and DHT production. Importantly, TP establishment significantly stimulated the phosphorylation of p65, one subunit of NF-κB, thus led to activation of the NF-κB signaling pathway in prostatic tissues of rats. In turn, the activation of NF-κB pathway induced concomitant upregulation of proinflammatory factors IL-1β, IL-6, TNF-α, and COX-2 and significant increase of the Bcl2/Bax expression ratio for enhanced cell survival, contributing to the initiation and progression of BPH in rats. Notably, CO therapy significantly decreased prostate weight and hyperplasia in BPH-induced animals. Also CO was found to suppress the expression of 5α-reductase and thus the production of DHT, which is essential for the amelioration of BPH. More importantly, CO was shown to suppress the activation of NF-κB pathway through decreasing the expression of phosphorylated p65 and consequently reduced the inflammatory responses and cell survival in prostatic tissues, leading to the inhibition of BPH development in rats.
CONCLUSION: Curcuma oil is very effective for ameliorating BPH in rats. The underlying mechanisms involve in reduced inflammatory responses and cell survival through suppression of the NF-κB signaling pathway by CO in prostatic tissues.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Apoptosis; Benign prostate hyperplasia; Curcuma oil; Inflammation; NF-κB signaling pathway

Mesh:

Substances:

Year:  2020        PMID: 33340599      PMCID: PMC9586842          DOI: 10.1016/j.jep.2020.113703

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   5.195


  48 in total

1.  Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.

Authors:  Byung-Ha Chung; Seung Hwan Lee; Claus G Roehrborn; Paul F Siami; Kim Major-Walker; Timothy H Wilson; Francesco Montorsi
Journal:  Int J Urol       Date:  2012-07-09       Impact factor: 3.369

Review 2.  The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).

Authors:  Giorgio Gandaglia; Alberto Briganti; Paolo Gontero; Nicola Mondaini; Giacomo Novara; Andrea Salonia; Alessandro Sciarra; Francesco Montorsi
Journal:  BJU Int       Date:  2013-04-12       Impact factor: 5.588

3.  Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation.

Authors:  Xiaohai Wang; Wen-Jye Lin; Kouji Izumi; Qi Jiang; Kuo-Pao Lai; Defeng Xu; Lei-Ya Fang; Tianjing Lu; Lei Li; Shujie Xia; Chawnshang Chang
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

Review 4.  EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.

Authors:  Matthias Oelke; Alexander Bachmann; Aurélien Descazeaud; Mark Emberton; Stavros Gravas; Martin C Michel; James N'dow; Jørgen Nordling; Jean J de la Rosette
Journal:  Eur Urol       Date:  2013-03-13       Impact factor: 20.096

5.  Simultaneous assessment of NF-κB/p65 phosphorylation and nuclear localization using imaging flow cytometry.

Authors:  Orla Maguire; Kieran O'Loughlin; Hans Minderman
Journal:  J Immunol Methods       Date:  2015-04-07       Impact factor: 2.303

Review 6.  Lower Urinary Tract Symptoms: What's New in Medical Treatment?

Authors:  Benoit Peyronnet; Benjamin M Brucker; Martin C Michel
Journal:  Eur Urol Focus       Date:  2018-04-14

7.  EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

Authors:  Stephan Madersbacher; Gerasimos Alivizatos; Jorgen Nordling; Carlos Rioja Sanz; Mark Emberton; Jean J M C H de la Rosette
Journal:  Eur Urol       Date:  2004-11       Impact factor: 20.096

Review 8.  Chemical constituents and biological research on plants in the genus Curcuma.

Authors:  Wen Sun; Sheng Wang; Wenwen Zhao; Chuanhong Wu; Shuhui Guo; Hongwei Gao; Hongxun Tao; Jinjian Lu; Yitao Wang; Xiuping Chen
Journal:  Crit Rev Food Sci Nutr       Date:  2017-05-03       Impact factor: 11.176

9.  Proliferation of prostate epithelia induced by IL-6 from stroma reacted with Trichomonas vaginalis.

Authors:  J-H Kim; I-H Han; Y-S Kim; C-S Noh; J-S Ryu
Journal:  Parasite Immunol       Date:  2018-04-26       Impact factor: 2.280

10.  Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice.

Authors:  Yong-Liang Li; Zhi-Yun Du; Peng-Hui Li; Longjia Yan; Wei Zhou; Ya-Dong Tang; Guang-Rong Liu; Yan-Xiong Fang; Kun Zhang; Chang-Zhi Dong; Hui-Xiong Chen
Journal:  Int Immunopharmacol       Date:  2018-09-19       Impact factor: 4.932

View more
  2 in total

Review 1.  Pharmacological Profile, Bioactivities, and Safety of Turmeric Oil.

Authors:  Adriana Monserrath Orellana-Paucar; María Gabriela Machado-Orellana
Journal:  Molecules       Date:  2022-08-09       Impact factor: 4.927

2.  Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia.

Authors:  Ramona D'Amico; Tiziana Genovese; Marika Cordaro; Rosalba Siracusa; Enrico Gugliandolo; Alessio Filippo Peritore; Livia Interdonato; Rosalia Crupi; Salvatore Cuzzocrea; Rosanna Di Paola; Roberta Fusco; Daniela Impellizzeri
Journal:  Antioxidants (Basel)       Date:  2021-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.